CA2425688A1 - Derives d'erythromycine a liberation prolongee - Google Patents
Derives d'erythromycine a liberation prolongee Download PDFInfo
- Publication number
- CA2425688A1 CA2425688A1 CA002425688A CA2425688A CA2425688A1 CA 2425688 A1 CA2425688 A1 CA 2425688A1 CA 002425688 A CA002425688 A CA 002425688A CA 2425688 A CA2425688 A CA 2425688A CA 2425688 A1 CA2425688 A1 CA 2425688A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- long chain
- host
- treating
- bacterial infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La présente invention concerne une composition pharmaceutique constituée d'un dérivé d'érythromycine et d'un matériau non polymère assurant la libération prolongée, plus particulièrement un élément sélectionné dans le groupe formé par les argiles, les hydrocarbures à longue chaîne, les acides carboxyliques à longue chaîne, les esters d'acide carboxylique à longue chaîne, les alcools à longue chaîne et les mélanges de ces derniers; ledit élément étant présent suivant une quantité suffisante pour assurer la libération prolongée du dérivé d'érythromycine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68998800A | 2000-10-13 | 2000-10-13 | |
US09/689,988 | 2000-10-13 | ||
PCT/US2001/032055 WO2002038577A2 (fr) | 2000-10-13 | 2001-10-12 | Derives d'erythromycine a liberation prolongee |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2425688A1 true CA2425688A1 (fr) | 2002-05-16 |
Family
ID=24770642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002425688A Abandoned CA2425688A1 (fr) | 2000-10-13 | 2001-10-12 | Derives d'erythromycine a liberation prolongee |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1333807A4 (fr) |
JP (1) | JP2004528272A (fr) |
AU (1) | AU2002239232A1 (fr) |
CA (1) | CA2425688A1 (fr) |
MX (1) | MXPA03003146A (fr) |
WO (1) | WO2002038577A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
JP2007502294A (ja) | 2003-08-12 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
EP1811986B1 (fr) * | 2004-11-04 | 2014-03-26 | XenoPort, Inc. | Formes posologiques orales a liberation prolongee d'un promedicament de la gabapentine |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3108046A (en) * | 1960-11-25 | 1963-10-22 | Smith Kline French Lab | Method of preparing high dosage sustained release tablet and product of this method |
JPS49107855A (fr) * | 1973-02-03 | 1974-10-14 | ||
JP2528652B2 (ja) * | 1987-03-30 | 1996-08-28 | エスエス製薬株式会社 | 持効性セフラジン製剤 |
US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
AU8219191A (en) * | 1990-06-14 | 1992-01-07 | Kalmo Enterprises, Inc. | Stable aqueous drug suspensions |
JP3265680B2 (ja) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
JPH07267850A (ja) * | 1994-03-28 | 1995-10-17 | Eisai Co Ltd | 不快味を防止した医薬組成物及びその製造方法 |
EP0826376B1 (fr) * | 1995-05-02 | 2007-01-24 | Taisho Pharmaceutical Co. Ltd | Composition s'administrant par voie orale |
US5858986A (en) * | 1996-07-29 | 1999-01-12 | Abbott Laboratories | Crystal form I of clarithromycin |
US6010718A (en) * | 1997-04-11 | 2000-01-04 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
US5780604A (en) * | 1997-09-26 | 1998-07-14 | Abbott Laboratories | 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides |
JP2000169364A (ja) * | 1998-09-30 | 2000-06-20 | Taisho Pharmaceut Co Ltd | 経口製剤用粒子 |
CN1343128B (zh) * | 1999-03-17 | 2010-04-21 | 第一制药株式会社 | 药物组合物 |
SI20244A (sl) * | 1999-05-19 | 2000-12-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Granulacija v talini |
-
2001
- 2001-10-12 JP JP2002541109A patent/JP2004528272A/ja active Pending
- 2001-10-12 AU AU2002239232A patent/AU2002239232A1/en not_active Abandoned
- 2001-10-12 MX MXPA03003146A patent/MXPA03003146A/es unknown
- 2001-10-12 WO PCT/US2001/032055 patent/WO2002038577A2/fr not_active Application Discontinuation
- 2001-10-12 CA CA002425688A patent/CA2425688A1/fr not_active Abandoned
- 2001-10-12 EP EP01986972A patent/EP1333807A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1333807A4 (fr) | 2005-06-29 |
WO2002038577A3 (fr) | 2002-09-19 |
MXPA03003146A (es) | 2004-12-06 |
WO2002038577A2 (fr) | 2002-05-16 |
EP1333807A2 (fr) | 2003-08-13 |
JP2004528272A (ja) | 2004-09-16 |
AU2002239232A1 (en) | 2002-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8633241B2 (en) | Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol | |
KR100638307B1 (ko) | HMG-CoA 환원효소 억제제를 포함하는 안정한 약학적조제물 | |
US4743450A (en) | Stabilized compositions | |
EP1901736B1 (fr) | Composition pharmaceutique comprenant de la simvastatine et de l'ézétimibe | |
US4562069A (en) | Two-phase formulation | |
EP1858514B1 (fr) | Comprimes pharmaceutiques de forme cristalline d'aripiprazole ii | |
EP2041084B1 (fr) | Co-cristaux de pyrrolidinones | |
AU2000249434A1 (en) | Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same | |
JP2004501121A (ja) | 安定した医薬効果を有する合成物、及びそれを含む医薬製剤 | |
EP1080721B1 (fr) | Dispersant solide noncristallin comprenant du céfuroxime axétil | |
KR100988233B1 (ko) | 클로피도그렐 1,5-나프탈렌 다이술폰산 염 또는 이의수화물의 약학 조성물 및 제제 | |
CA2425688A1 (fr) | Derives d'erythromycine a liberation prolongee | |
CA2355239C (fr) | Formulations pharmaceutiques | |
AU7863098A (en) | Pharmaceutical preparations of cilansetron stabilized against racemization | |
EP1296672B1 (fr) | Produit et preparation pharmaceutiques stables | |
US20040157925A1 (en) | Stable pharmaceutical composition of pravastatin | |
WO2011034514A2 (fr) | Granulés micronisés stables présentant une solubilité élevée | |
AU3940999A (en) | Novel formulation containing paroxetine | |
MXPA98006166A (en) | Pharmaceutical preparations of cilansetron stabilized against the racemizac | |
MXPA00011154A (en) | Novel formulation containing paroxetine | |
MXPA00006292A (en) | Hyperhydrated citicoline, process and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |